Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Endocrinology
•
Bone and Calcium Disorders
Do you recommend a particular antiresorptive/anabolic agent for patients who are at high risk for fractures but have high risk of osteonecrosis of the jaw?
Related Questions
How do you manage osteoporosis in patients with anorexia nervosa (who often are young women < 40)?
What is your approach to managing osteoporosis in patients with end stage kidney disease?
Can romosozumab be used for patients who develop osteoporosis secondary to mild autonomous cortisol excess?
Would you start anabolic agents for osteoporotic hip fracture healing?
After completing 12 months romosozumab, what is the next best treatment option for patients with severe osteoporosis, high risk for fracture, and normal kidney function?
Have the results of the ancillary study of the VITAL trial, demonstrating that Vitamin D3 supplementation did not reduce the incident rate of fractures in generally healthy midlife and older adults, changed how you prescribe Vitamin D?
How do you view the efficacy of estrogen replacement therapy in trans-women with regards to osteoporosis prevention and treatment?
How do you distinguish between primary and tertiary hyperparathyroidism in a patient with ESRD?
Is there any data or advice on using teriparatide after romosozumab for treatment of postmenopausal osteoporosis?
Is it possible for certain individuals with osteoporosis to be a denosumab "non-responder"?